Product Categories
| Country: | China |
|---|---|
| Tel: | 0574-27855777 |
| Mobile: | 18758850676 |
| E-mail: | info@unibestcn.com |
| QQ: | 851997603 |
| Skype: | Chat Now! |
| Address: | 11F, Bldg.1, Yinchen International Mansion, 315100, Ningbo, P. R. China |
|
Unibest Industrial Co., Ltd. was founded in September, 2003. We have been always improving and developing ourselves in the wave of economic globalization for more than 15 years. UNIBEST focused on the development of international trade and input of product investment. We have passed the ISO9001 Quality Management System Certification. UNIBEST has been always following the direction of enterprise development, grasping the opportunities and facing big challenges when the world trade pattern is changing greatly. We have achieved cross domain development success on the basis of enterprise steady growth and innovation.
Now UNIBEST has two subsidiaries: Unibest Industrial Co., Ltd. Unibest Biopharma (Shanghai) Co., Ltd. We have covered the field of APIs, Pharmaceutical intermediates, Pharmaceutical formulation etc. UNIBEST turnover in 2020 already reached more than 50 million USD.
UNIBEST found its own strategy during years’ experience which combined research, production and trade together. UNIBEST always offers excellent professional service and achieved great credibility. UNIBEST is standing out of the price-competition market with technological innovation and professional talents. In the meanwhile, UNIBEST reinforces the cultivation of brand, implement brand strategy and network marketing.
UNIBEST has its own integral R&D and production system. UNIBEST BIOPHARMA (SHANGHAI) CO., LTD. which was founded in February, 2007 specialized in R&D, production and management of various pharmaceutical intermediates, polymer material monomers and other fine chemical products. In the aim of GREEN CHEMISTRY and PEOPLE ORIENTED, it operates strictly accordance with HSEQ (health, security, environment, quality) STANDARD OF SHANGHAI CHEMICAL INDUSTRY. UNIBEST always follows the enterprise spirit of “Quality is the life of the enterprise, always improving and being better”. UNIBEST (SHANGHAI) has established a perfect quality assurance system according to ISO9001:2015. And it
|
|
| Product Name | MF | CAS | Details |
|---|
| (3R,4S)-3-(2-Bromoacetyl)-4-ethyl-1-pyrrolidinecarboxylic acid phenylmethyl ester | C34H39N5O7S | 1428243-27-9 | Details |
| 8-((3R,4S)-4-ethylpyrrolidin-3-yl)-3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazine | C14H17N5 | 1708997-43-6 | Details |
| ethyl-2,2-dimethyl-7-bromoheptanoate | C11H21BrO2 | 123469-92-1 | Details |
| (2R,4S)-5-([1,1'-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)aMino)-2-Methylpentanoic acid | C23H29NO4 | 1012341-50-2 | Details |
| (2S,5R)-5-[(Benzyloxy)Amino]Piperidine-2-Carboxamide | C13H19N3O2 | 1416134-49-0 | Details |
| N-(5-Methoxy-2-Phenoxyphenyl)Methanesulfonamide | C14H15NO4S | 123664-84-6 | Details |
| (2S,5R)-6-(Benzyloxy)-7-Oxo-1,6-Diazabicyclo[3.2.1]Octane-2-Carboxamide | C14H17N3O3 | 1192651-49-2 | Details |
| D-erythro-Pentonic acid, 2-deoxy-4-C-ethynyl-, γ-lactone | C7H8O4 | 2072080-26-1 | Details |
| Baloxavir | C24H19F2N3O4S | 1985605-59-1 | Details |
| C23H20O6 | 2072080-27-2 | Details |
| (R)-7-(Benzyloxy)- 3,4,12,12A-Tetrahydro- 1H-[1,4]Oxazino[3,4- C]Pyrido[2,1-F][1,2,4]- Triazine-6,8-Dione | C17H17N3O4 | 1985607-70-2 | Details |
| Tetrabutylammonium (1R,2S,5R)-2-carbamoyl-7-oxo-1,6-diazabicyclo[3.2.1]octan-6-yl sulfate | C23H46N4O6S | 1192651-80-1 | Details |
| 5-chloro-6-[4-(ethoxycarbonyl)piperidino]nicotinic acid | C14H17ClN2O4 | 931395-73-2 | Details |
| 7-(Benzyloxy)-3,4,12,12a-tetrahydro-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione | C17H17N3O4 | 1370250-39-7 | Details |
| MethanesulfonaMide, N-[4-[2-(forMylaMino)acetyl]-5-hydroxy-2-phenoxyphenyl]- | C16H16N2O6S | 149457-03-4 | Details |
| 7,8-Difluoro-6,11-Dihydrodibenzo[B,E]Thiepin-11-Ol | C14H10F2OS | 1985607-83-7 | Details |
| D-erythro-Pentonic acid, 2-deoxy-4-C-ethynyl-4,5-O-(1-methylethylidene)-, 1,1-dimethylethyl ester | C14H22O5 | 2072080-25-0 | Details |
| C23H22O6 | 2596091-21-1 | Details |
| D-erythro-Pentofuranose, 2-deoxy-4-C-ethynyl-, 1-acetate 3,5-bis(4-methylbenzoate) | C25H24O7 | 2072080-28-3 | Details |
| 5-Bromo-4-fluoro-1-methyl-1H-indazole | C8H6BrFN2 | 1784678-61-0 | Details |
| Butanedioic acid, 2,3-bis[(4-methylbenzoyl)oxy]-, (2R,3R)-, compd. with ethyl (2R,3S)-2-[4-(cyclopentylamino)phenyl]-3-piperidinecarboxylate (2:1) | C39H46N2O10 | 1893415-79-6 | Details |
| [4-(2-Phenyl-1H-benzimidazol-1-yl)phenyl]boronic acid | C19H15BN2O2 | 867044-33-5 | Details |
| Phenylboronic acid | C6H7BO2 | 98-80-6 | Details |
| methyl 8-amino-2,3-dimethylimidazo[1,2-a]pyridine-6-carboxylate | C11H13N3O2 | 248919-96-2 | Details |
| " Imidazo[1,2-a]pyridine-6-carboxylic acid, 8-amino-2,3-dimethyl-, methyl ester, hydrochloride (1:1)" | C11H13N3O2.ClH | 2892564-07-5 | Details |
| UNDECYLENICACIDMONOETHANOLAMIDE | C13H25NO2 | 20545-92-0 | Details |
| GS-6207 | C39H32ClF10N7O5S2 | 2189684-44-2 | Details |
| 2-Pyridinemethanamine, 3-bromo-α-[(3,5-difluorophenyl)methyl]-6-[3-methyl-3-(methylsulfonyl)-1-butyn-1-yl]-, (αS)- | C19H19BrF2N2O2S | 2375019-85-3 | Details |
| 3-(Perfluorobutyl)propyl acrylate | C12H9F13O2 | 216389-85-4 | Details |
| Lenacapavir impurity | C29H24BrF7N4O3S | 2375020-19-0 | Details |
| 4-IMIDAZOLEACETIC ACID HYDROCHLORIDE | C5H7ClN2O2 | 3251-69-2 | Details |
| 1H-Indazole-5-carboxaldehyde, 7-methyl- (9CI) | C9H8N2O | 635712-40-2 | Details |
| 5-Bromoindole-2-carboxylic acid | C9H6BrNO2 | 7254-19-5 | Details |
| 1,1'-Bi-2-naphthol | C20H14O2 | 602-09-5 | Details |
| (S)-3-Aminobutanenitrile hydrochloride | C4H9ClN2 | 1073666-54-2 | Details |
| (S)-4-Methyl-1,3,2-dioxathiolane 2,2-dioxide | C3H6O4S | 174953-30-1 | Details |
| (4-Fluoro-3,5-dimethylphenyl)hydrazine hydrochloride | C8H12ClFN2 | 2212021-40-2 | Details |
| 5-bromo-4-fluoro-1H-indazole | C7H4BrFN2 | 1082041-85-7 | Details |
| 5,6-DIAMINOPYRIDINE-3-CARBOXYLIC ACID METHYL ESTER | C7H9N3O2 | 104685-76-9 | Details |
| Lenacapavir impurity | 3025145-48-3 | Details |
| Lenacapavir Impurity 53 | 3025145-45-0 | Details |
| Lenacapavir impurity | C39H32ClF10N7O5S2 | 3060953-29-6 | Details |
| Lenacapavir impurity | 2375021-50-2 | Details |
| Lenacapavir impurity | C40H34ClF10N7O5S2 | 2939763-16-1 | Details |
| 1H-Cyclopropa[3,4]cyclopenta[1,2-c]pyrazole-1-acetamide, N-[(1S)-1-[3-[4-chloro-3-[(methylsulfonyl)amino]-1-(2,2,2-trifluoroethyl)-1H-indazol-7-yl | C39H33ClF10N7NaO5S2 | 2283356-12-5 | Details |
| 1H-Cyclopropa[3,4]cyclopenta[1,2-c]pyrazole-1-acetamide, N-[(1S)-1-[3-[3-[bis(methylsulfonyl)amino]-4-chloro-1-(2,2,2-trifluoroethyl)-1H-indazol-7-y | C40H34ClF10N7O7S3 | 2189684-58-8 | Details |
| N-Acetylcaprolactam | C8H13NO2 | 1888-91-1 | Details |
| 3-Methyldodec-1-yn-3-0] | C13H24O | 24424-78-0 | Details |
| 1-cyclopropyl-7-fluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid | C14H12FNO4 | 221221-16-5 | Details |
| Carbamic acid, N-[(3S,5S)-5-methyl-3-piperidinyl]-, 1,1-dimethylethyl ester | C11H22N2O2 | 951163-61-4 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 | ||||